Pharma Mar SA operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharma Mar SA with three other
miscellaneous service companies in Europe:
sales of 155.92 million Euro [US$183.65 million]
of which 76%
(158.09 million Swiss Francs [US$159.20 million]
Bavarian Nordic AS
based in Denmark
(1.37 billion Danish Kroner [US$216.69 million]
During the year ended December of 2017, sales at
Pharma Mar SA were 179.36 million Euro (US$211.26 million).
decrease of 0.9%
versus 2016, when the company's sales were 180.95 million Euro.